1. Interactions between iron and α-synuclein pathology in Parkinson's disease
    Bingbing Chen et al, 2019, Free Radical Biology and Medicine CrossRef
  2. PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation
    Weiwei Yang et al, 2018, Oncotarget CrossRef
  3. Alzheimer’s Disease and Dementia
    Michael Harper et al, 2020, Urological Care for Patients with Progressive Neurological Conditions CrossRef
  4. Dysregulation of Human Somatic piRNA Expression in Parkinson’s Disease Subtypes and Stages
    Tianjiao Zhang et al, 2022, International Journal of Molecular Sciences CrossRef
  5. Loss of PINK1 inhibits apoptosis by upregulating α-synuclein in inflammation-sensitized hypoxic-ischemic injury in the immature brains
    Jianghu Zhu et al, 2016, Brain Research CrossRef
  6. La transconformation protéique, nouveau paradigme en neurologie
    J.-J. Hauw et al, 2015, Revue Neurologique CrossRef
  7. Cytoprotection against Hypoxic and/or MPP+ Injury: Effect of δ–Opioid Receptor Activation on Caspase 3
    Yuan Xu et al, 2016, International Journal of Molecular Sciences CrossRef
  8. The delta‐opioid receptor and Parkinson’s disease
    Jin‐Zhong Huang et al, 2018, CNS Neuroscience & Therapeutics CrossRef
  9. The Lewy body dementias
    Richard R. Murphy et al, 2016, The Behavioral Neurology of Dementia CrossRef
  10. Alpha synuclein protein is involved in Aluminum-induced cell death and oxidative stress in PC12 cells
    Jamileh Saberzadeh et al, 2016, Brain Research CrossRef